References
- de BoerTThe effects of mirtazapine on central noradrenergic and serotonergic neurotransmissionInt Clin Psychopharmacol199510suppl 41923
- HaddjeriNBlierPde MontignyCNoradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapineInt Clin Psychopharmacol199510suppl 41117
- ThaseMENierenbergAAVrijlandPvan OersHJSchutteAJSimmonsJHRemission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depressionInt Clin Psychopharmacol201025418919820531012
- WatanabeNOmoriIMNakagawaAMirtazapine versus other antidepressive agents for depressionCochrane Database Syst Rev201112CD00652822161405
- WatanabeNOmoriIMNakagawaAMirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysisJ Clin Psychiatry20086991404141519193341
- RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry2006163111905191717074942
- FunakiKNakajimaSSuzukiTMimuraMUchidaHEarly improvements in individual symptoms to predict later remission in major depressive disorder treated with mirtazapineJ Clin Pharmacol Epub2016127
- NuttDJTolerability and safety aspects of mirtazapineHum Psychopharmacol200217suppl 1S37S4112404669
- MontgomerySASafety of mirtazapine: a reviewInt Clin Psychopharmacol199510suppl 43745
- FriedmanRALeonACExpanding the black box – depression, antidepressants, and the risk of suicideN Engl J Med2007356232343234617485726
- HaradaTInadaKYamadaKSakamotoKIshigookaJA prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndromeNeuropsychiatrDis Treat20141021152121
- YamaokaKNakagawaTUnoTApplication of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJ Pharmacokinet Biopharm197862165175671222
- FangYYuanCXuYComparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese populationJ Clin Psychopharmacol201030435736420571433
- NagaoKKishiTMoriwakiMComparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorderNeuropsychiatr Dis Treat2013978178623766648
- SechterDVandelPWeillerEstudy co-coordinatorsA comparative study of milnacipran and paroxetine in outpatients with major depressionJ Affect Disord2004832–323323615555719
- HiguchiHSatoKYoshidaKNo predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disordersPsychiatry Clin Neurosci200862219720218412843
- MartinotMBragulatVArtigesEDecreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardationAm J Psychiatry2001158231431611156819
- GerraMLMarchesiCAmatJABlierPHellersteinDJStewartJWDoes negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?J Clin Psychiatry2014759e939e94425295437
- RadhakishunFSvan den BosJvan der HeijdenBCRoesKCO’HanlonJFMirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimensJ Clin Psychopharmacol200020553153711001237
- BailerUFischerPKufferleBStastnyJKasperSOccurrence of mirtazapine-induced delirium in organic brain disorderInt Clin Psychopharmacol200015423924310954066
- LadinoMGuardiolaVDPaniaguaMMirtazapine-induced hyponatremia in an elderly hospice patientJ Palliat Med20069225826016629552
- SinclairLIChristmasDMHoodSDAntidepressant-induced jitteriness/anxiety syndrome: systematic reviewBr J Psychiatry2009194648349019478285
- HammadTALaughrenTRacoosinJSuicidality in pediatric patients treated with antidepressant drugsArch Gen Psychiatry200663333233916520440
- CouplandCHillTMorrissRArthurAMooreMHippisley-CoxJAntidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care databaseBMJ2015350h51725693810